Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Deep neuromuscular blockade-Seoul National University Hospital refers to a specific pharmacological intervention protocol evaluated in clinical trials conducted by Seoul National University Hospital. This technique involves the administration of the non-depolarizing neuromuscular blocking agent rocuronium at high doses (typically an induction dose of 0.8 mg/kg followed by maintenance doses of 0.3 mg/kg) to achieve a profound state of muscle relaxation, defined by a post-tetanic count (PTC) of 1-2 twitches. The protocol is primarily investigated for its utility in laparoscopic colorectal surgery, where it is used in conjunction with low-pressure pneumoperitoneum to improve surgical field conditions and minimize the adverse cardiopulmonary effects associated with the Trendelenburg position and standard intra-abdominal pressures. The blockade is typically reversed using sugammadex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on deep neuromuscular blockade-Seoul National University Hospital.